載入...
The Novel mTOR Complex 1/2 Inhibitor P529 Inhibits Human Lung Myofibroblast Differentiation
Idiopathic pulmonary fibrosis is a progressive and deadly disorder with very few therapeutic options. Palomid 529 (8-(1-hydroxyethyl)-2-methoxy-3-(4-methoxybenzyloxy)-benzo[c]chromen-6-one; P529) is a novel dual inhibitor of mechanistic target of rapamycin complex 1/2 (mTORC1/2). In these studies, w...
Na minha lista:
| 發表在: | J Cell Biochem |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5568785/ https://ncbi.nlm.nih.gov/pubmed/28078713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.25878 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|